Sponsor

Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany

Clinical research sponsor

Published trials12
Recruiting shown0
Roles2
SourceClinicalTrials.gov

Clinical trials

12 shown
Cladribine Tablets Level of Response Predictors in Clinical Practice (CLODINA)NCT05797740 · lead sponsor · 2023-08-03
ACTIVE_NOT_RECRUITING
A Study to Investigate the Association of Real-world Sensor-derived Biometric Data With Clinical Parameters and Patient-reported Outcomes for Monitoring Disease Activity in Patients With COPDNCT05655832 · lead sponsor · 2022-12-05
COMPLETED
Effectiveness of Cladribine Tablets in Participants With Highly-active Relapsing Multiple Sclerosis (CAMELOT-MS)NCT04997148 · lead sponsor · 2021-08-11
COMPLETED
Extension to the MAGNIFY MS Trial on Mavenclad® (Magnify MS Extension)NCT04783935 · lead sponsor · 2021-03-10
COMPLETED
Cognition and HRQoL in Adults With Highly-active RMS in Year 3 and 4 After Initial Mavenclad® Dose (CLARIFY MS Extension)NCT04776213 · lead sponsor · 2021-02-23
COMPLETED
GXR RM (Glucophage® Extended Release Reduced Mass) 500 Milligram (mg) Korea Bioequivalence (BE) StudyNCT04684420 · lead sponsor · 2020-12-22
COMPLETED
Study of Evobrutinib in Participants With RMS (evolutionRMS 2)NCT04338061 · lead sponsor · 2020-07-02
TERMINATED
Study of Evobrutinib in Participants With RMS (evolutionRMS 1)NCT04338022 · lead sponsor · 2020-06-12
TERMINATED
Prospective Effectiveness and Safety Study of Cladribine in Participants Who Change First-line DMD Treatments for Multiple Sclerosis (CLAD CROSS)NCT04934800 · lead sponsor · 2019-12-10
COMPLETED
Study of Anti-CEACAM5 ADC M9140 in Participants With Advanced Solid Tumors (PROCEADE PanTumor)NCT06710132 · collaborator · 2025-01-29
ACTIVE_NOT_RECRUITING
Effects of a Multiple Sclerosis Relapse Therapy on Offspring Neurocognitive Development and BehaviourNCT04832269 · collaborator · 2020-10-19
UNKNOWN
Bintrafusp Alfa in High Mobility Group AT-Hook 2 (HMGA2) Expressing Triple Negative Breast CancerNCT04489940 · collaborator · 2020-10-12
TERMINATED

Sponsor roles

lead sponsor9
collaborator3

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.